[SCHEDULE 13G/A] Structure Therapeutics Inc. American SEC Filing
Wellington Management disclosed beneficial ownership of 20,627,307 shares of Structure Therapeutics common stock, representing 11.95% of the class. The filing shows no sole voting or dispositive power and reports shared voting power of 19,646,661 and shared dispositive power of 20,627,307, indicating these securities are managed jointly across Wellington entities. The shares are owned of record by clients of Wellington Investment Advisers rather than by Wellington as principal.
The filing also states the holdings were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control. One named client, Vanguard Health Care Fund, is identified as an exception to the general statement about clients.
Wellington Management ha dichiarato la propriet脿 beneficiaria di 20,627,307 azioni ordinarie di Structure Therapeutics, pari all'11.95% della classe. La comunicazione indica assenza di potere di voto o di disposizione in via esclusiva e riporta potere di voto condiviso di 19,646,661 e potere di disposizione condiviso di 20,627,307, segnalando che questi titoli sono gestiti congiuntamente tra le entit脿 di Wellington. Le azioni risultano intestate a clienti di Wellington Investment Advisers e non a Wellington come principale.
La dichiarazione precisa inoltre che le partecipazioni sono state acquisite e sono detenute nell'ordinaria attivit脿 d'impresa e non con l'intento di modificare o influenzare il controllo. Un cliente nominato, il Vanguard Health Care Fund, 猫 indicato come eccezione a questa affermazione generale riguardo ai clienti.
Wellington Management declar贸 la propiedad beneficiaria de 20,627,307 acciones ordinarias de Structure Therapeutics, lo que representa el 11.95% de la clase. La presentaci贸n muestra ausencia de poder de voto o de disposici贸n en forma exclusiva y reporta poder de voto compartido de 19,646,661 y poder de disposici贸n compartido de 20,627,307, indicando que estos valores se gestionan de forma conjunta entre las entidades de Wellington. Las acciones figuran registradas a nombre de clientes de Wellington Investment Advisers y no a nombre de Wellington como principal.
La presentaci贸n tambi茅n se帽ala que las posiciones fueron adquiridas y se mantienen en el curso ordinario del negocio y no con el prop贸sito de cambiar o influir en el control. Un cliente nombrado, el Vanguard Health Care Fund, se identifica como excepci贸n a la declaraci贸n general sobre los clientes.
鞗半韯� 毵る媹歆�毹柬姼(Wellington Management)電� Structure Therapeutics 氤错喌欤� 20,627,307欤�(頃措嫻 韥措灅鞀れ潣 11.95%)鞚� 鞁れ鞝� 靻岇湢毳� 瓿奠嫓頄堨姷雼堧嫟. 鞝滌稖 靹滊鞐愲姅 雼弲 鞚橁舶甓� 霕愲姅 觳橂秳甓岇澊 鞐嗢潓鞚� 響滌嫓霅橃柎 鞛堨溂氅�, 瓿惦彊 鞚橁舶甓� 19,646,661欤�鞕赌 瓿惦彊 觳橂秳甓� 20,627,307欤�臧� 氤搓碃霅橃柎 鞚措煬頃� 歃濌秾鞚� 鞗半韯� 瓿勳棿靷摛鞐� 鞚橅暣 瓿惦彊鞙茧 甏�毽悩瓿� 鞛堨潓鞚� 雮橅儉雰呺媹雼�. 頃措嫻 欤检嫕鞚� 鞗半韯挫澊 歆侅爲 氤挫湢頃� 瓴冹澊 鞎勲媹霛� Wellington Investment Advisers鞚� 瓿犼皾 氇呾潣搿� 霌膘灛霅橃柎 鞛堨姷雼堧嫟.
靹滊鞐愲姅 霕愴暅 鞚� 氤挫湢攵勳澊 韱奠儊鞝侅澑 鞓侅梾頇滊彊鞚� 鞚柬櫂鞙茧 旆摑路氤挫湢霅� 瓴冹澊氅� 歆�氚瓣秾鞚� 氤�瓴巾晿瓯半倶 鞓來枼霠レ潉 頄夓偓頃� 氇╈爜鞙茧 氤挫湢霅� 瓴冹澊 鞎勲嫎鞚� 氇呾嫓頃橁碃 鞛堨姷雼堧嫟. 雼る 氇呾嫓霅� 瓿犼皾 欷� 頃橂倶鞚� Vanguard Health Care Fund電� 瓿犼皾 甏�霠� 鞚茧皹 歆勳垹鞚� 鞓堨櫢搿� 歆�氇╇悩鞏� 鞛堨姷雼堧嫟.
Wellington Management a d茅clar茅 la propri茅t茅 b茅n茅ficiaire de 20,627,307 actions ordinaires de Structure Therapeutics, repr茅sentant 11.95% de la cat茅gorie. Le d茅p么t indique absence de pouvoir de vote ou de disposition exclusif et signale un pouvoir de vote partag茅 de 19,646,661 et un pouvoir de disposition partag茅 de 20,627,307, ce qui montre que ces titres sont g茅r茅s conjointement par les entit茅s de Wellington. Les actions sont inscrites au registre au nom de clients de Wellington Investment Advisers et non au nom de Wellington en tant que principal.
Le d茅p么t pr茅cise 茅galement que les participations ont 茅t茅 acquises et sont d茅tenues dans le cours normal des affaires et non dans le but de modifier ou d'influencer le contr么le. Un client nomm茅, le Vanguard Health Care Fund, est identifi茅 comme exception 脿 l'茅nonc茅 g茅n茅ral concernant les clients.
Wellington Management gab die wirtschaftliche Eigent眉merschaft an 20,627,307 Stammaktien von Structure Therapeutics bekannt, was 11,95% der Klasse entspricht. Die Meldung weist kein alleiniges Stimm- oder Verf眉gungsrecht aus und meldet gemeinsame Stimmrechte von 19,646,661 sowie gemeinsame Verf眉gungsrechte von 20,627,307, was darauf hindeutet, dass diese Wertpapiere gemeinsam 眉ber mehrere Wellington-Einheiten verwaltet werden. Die Aktien sind im Register auf Kunden von Wellington Investment Advisers eingetragen und nicht auf Wellington als Prinzipal.
Die Meldung stellt ferner klar, dass die Best盲nde im normalen Gesch盲ftsverlauf erworben und gehalten wurden und nicht mit dem Ziel, die Kontrolle zu 盲ndern oder zu beeinflussen. Ein namentlich genannter Kunde, der Vanguard Health Care Fund, wird als Ausnahme von der allgemeinen Aussage zu den Kunden genannt.
- Material disclosure of stake: Wellington reports ownership of 20,627,307 shares (11.95%), a clearly quantified, material position.
- Clear voting/dispositive breakdown: Filing provides specific shared voting power (19,646,661) and shared dispositive power (20,627,307), improving transparency.
- Passive intent certified: The statement certifies holdings are in the ordinary course of business and not held to change or influence control.
- Client exception noted: The filing names Vanguard Health Care Fund as an exception but does not quantify that client鈥檚 percentage, reducing clarity on single-client concentration.
- No sole control: The reporting entities state zero sole voting or dispositive power, meaning Wellington does not exercise individual control despite the large aggregate stake.
Insights
TL;DR: Wellington reports a material, approximately 12% passive stake in Structure Therapeutics, disclosed as shared voting and dispositive power.
Wellington Management Group and related entities together report beneficial ownership of 20,627,307 shares (11.95%) with shared voting power of 19,646,661. The Schedule 13G classification and the signed certification indicate a passive, non-control intent, which typically signals confidence by large asset managers without an activist agenda. For investors, the holding is material in size and could affect float and liquidity analyses, but the filing contains no indication of plans to change governance or strategy.
TL;DR: A sizable passive stake is disclosed; governance impact appears limited because the filer certifies no intent to influence control.
The report clarifies that ownership is through clients of Wellington Investment Advisers and that there is no sole voting or dispositive power reported. While the position is material at 11.95% of the class, the explicit certification that the shares are held in the ordinary course and not to influence control suggests limited immediate governance engagement. Notably, the filing identifies Vanguard Health Care Fund as an exception where a client may have separate significance, which should be tracked by stakeholders seeking clarity on shareholder composition.
Wellington Management ha dichiarato la propriet脿 beneficiaria di 20,627,307 azioni ordinarie di Structure Therapeutics, pari all'11.95% della classe. La comunicazione indica assenza di potere di voto o di disposizione in via esclusiva e riporta potere di voto condiviso di 19,646,661 e potere di disposizione condiviso di 20,627,307, segnalando che questi titoli sono gestiti congiuntamente tra le entit脿 di Wellington. Le azioni risultano intestate a clienti di Wellington Investment Advisers e non a Wellington come principale.
La dichiarazione precisa inoltre che le partecipazioni sono state acquisite e sono detenute nell'ordinaria attivit脿 d'impresa e non con l'intento di modificare o influenzare il controllo. Un cliente nominato, il Vanguard Health Care Fund, 猫 indicato come eccezione a questa affermazione generale riguardo ai clienti.
Wellington Management declar贸 la propiedad beneficiaria de 20,627,307 acciones ordinarias de Structure Therapeutics, lo que representa el 11.95% de la clase. La presentaci贸n muestra ausencia de poder de voto o de disposici贸n en forma exclusiva y reporta poder de voto compartido de 19,646,661 y poder de disposici贸n compartido de 20,627,307, indicando que estos valores se gestionan de forma conjunta entre las entidades de Wellington. Las acciones figuran registradas a nombre de clientes de Wellington Investment Advisers y no a nombre de Wellington como principal.
La presentaci贸n tambi茅n se帽ala que las posiciones fueron adquiridas y se mantienen en el curso ordinario del negocio y no con el prop贸sito de cambiar o influir en el control. Un cliente nombrado, el Vanguard Health Care Fund, se identifica como excepci贸n a la declaraci贸n general sobre los clientes.
鞗半韯� 毵る媹歆�毹柬姼(Wellington Management)電� Structure Therapeutics 氤错喌欤� 20,627,307欤�(頃措嫻 韥措灅鞀れ潣 11.95%)鞚� 鞁れ鞝� 靻岇湢毳� 瓿奠嫓頄堨姷雼堧嫟. 鞝滌稖 靹滊鞐愲姅 雼弲 鞚橁舶甓� 霕愲姅 觳橂秳甓岇澊 鞐嗢潓鞚� 響滌嫓霅橃柎 鞛堨溂氅�, 瓿惦彊 鞚橁舶甓� 19,646,661欤�鞕赌 瓿惦彊 觳橂秳甓� 20,627,307欤�臧� 氤搓碃霅橃柎 鞚措煬頃� 歃濌秾鞚� 鞗半韯� 瓿勳棿靷摛鞐� 鞚橅暣 瓿惦彊鞙茧 甏�毽悩瓿� 鞛堨潓鞚� 雮橅儉雰呺媹雼�. 頃措嫻 欤检嫕鞚� 鞗半韯挫澊 歆侅爲 氤挫湢頃� 瓴冹澊 鞎勲媹霛� Wellington Investment Advisers鞚� 瓿犼皾 氇呾潣搿� 霌膘灛霅橃柎 鞛堨姷雼堧嫟.
靹滊鞐愲姅 霕愴暅 鞚� 氤挫湢攵勳澊 韱奠儊鞝侅澑 鞓侅梾頇滊彊鞚� 鞚柬櫂鞙茧 旆摑路氤挫湢霅� 瓴冹澊氅� 歆�氚瓣秾鞚� 氤�瓴巾晿瓯半倶 鞓來枼霠レ潉 頄夓偓頃� 氇╈爜鞙茧 氤挫湢霅� 瓴冹澊 鞎勲嫎鞚� 氇呾嫓頃橁碃 鞛堨姷雼堧嫟. 雼る 氇呾嫓霅� 瓿犼皾 欷� 頃橂倶鞚� Vanguard Health Care Fund電� 瓿犼皾 甏�霠� 鞚茧皹 歆勳垹鞚� 鞓堨櫢搿� 歆�氇╇悩鞏� 鞛堨姷雼堧嫟.
Wellington Management a d茅clar茅 la propri茅t茅 b茅n茅ficiaire de 20,627,307 actions ordinaires de Structure Therapeutics, repr茅sentant 11.95% de la cat茅gorie. Le d茅p么t indique absence de pouvoir de vote ou de disposition exclusif et signale un pouvoir de vote partag茅 de 19,646,661 et un pouvoir de disposition partag茅 de 20,627,307, ce qui montre que ces titres sont g茅r茅s conjointement par les entit茅s de Wellington. Les actions sont inscrites au registre au nom de clients de Wellington Investment Advisers et non au nom de Wellington en tant que principal.
Le d茅p么t pr茅cise 茅galement que les participations ont 茅t茅 acquises et sont d茅tenues dans le cours normal des affaires et non dans le but de modifier ou d'influencer le contr么le. Un client nomm茅, le Vanguard Health Care Fund, est identifi茅 comme exception 脿 l'茅nonc茅 g茅n茅ral concernant les clients.
Wellington Management gab die wirtschaftliche Eigent眉merschaft an 20,627,307 Stammaktien von Structure Therapeutics bekannt, was 11,95% der Klasse entspricht. Die Meldung weist kein alleiniges Stimm- oder Verf眉gungsrecht aus und meldet gemeinsame Stimmrechte von 19,646,661 sowie gemeinsame Verf眉gungsrechte von 20,627,307, was darauf hindeutet, dass diese Wertpapiere gemeinsam 眉ber mehrere Wellington-Einheiten verwaltet werden. Die Aktien sind im Register auf Kunden von Wellington Investment Advisers eingetragen und nicht auf Wellington als Prinzipal.
Die Meldung stellt ferner klar, dass die Best盲nde im normalen Gesch盲ftsverlauf erworben und gehalten wurden und nicht mit dem Ziel, die Kontrolle zu 盲ndern oder zu beeinflussen. Ein namentlich genannter Kunde, der Vanguard Health Care Fund, wird als Ausnahme von der allgemeinen Aussage zu den Kunden genannt.
FAQ
How many shares of GPCR does Wellington report owning?
Does Wellington have sole voting or dispositive power over these GPCR shares?
Which Wellington entities filed this Schedule 13G/A for GPCR?
Is Wellington seeking to influence control of Structure Therapeutics (GPCR)?
Who holds the securities of record according to the filing?
